MicroVue™ YKL-40 EIA

The MicroVue YKL-40 is a test to measure YKL-40, also known as human cartilage 39 (HC gp-39), in serum and human cell cultures.


Product Specifications

Citations 0
Specimen

Serum/EDTAPlasma 20 μL

LLOQ N/A
ULOQ N/A
Assay Time 3 hours
Cross Reactivity

Baboon, Cynomolgous monkey, Rhesus monkey

Ordering Information

For Research Use Only. Not for use in diagnostic procedures.
Catalog Number 8020
Catalog Number (CE)  
Size 96 wells/test
Price (USD) $970.00
Price (EURO) 680,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

The MicroVue YKL-40 is a test to measure YKL-40, also known as human cartilage 39 (HC gp-39), in serum and human cell cultures.

Size 96 wells/test
Form

96 well plate with 12 eight-well strips in a resealable foil pouch

Specimen Serum/EDTAPlasma 20 μL
Limit of Detection (LOD) 5.4 ng/mL
Lower Limit of Quantitation (LLOQ) N/A
Upper Limit of Quantitation (ULOQ) N/A
Intra Assay 5.6-6.6%
Inter Assay 6.0-7.0%
Standards 6
Controls 2
Sample Values

Adult (EDTA Plasma) 20-130 ng/mL, Females (Serum) 25-93 ng/mL, Males (Serum) 24-125 ng/mL

Assay Time 3 hours
Cross Reactivity

Baboon, Cynomolgous monkey, Rhesus monkey

Storage

Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components

Background

YKL-40 — also known as human cartilage glycoprotein 39 (HC gp-39) is a 40 KD glycoprotein first described in whey secretions of nonlactating cows. Subsequently, its production by chondrocytes, synovial cells, activated macrophages, neutrophils, and osteosarcoma cells (MG-63) has been reported. It has both heparin and chitin binding domains and appears to be an autoantigen in rheumatoid arthritis. Early studies suggest YKL-40 is useful for researching:Rheumatoid Arthritis, Early polyarthritis, Osteoarthritis, Giant cell arteritis, Liver fibrosis, Breast cancer, Colorectal cancer. Recently, serum YKL-40 has been investigated as a new marker for cancer. Elevated serum YKL-40 is associated in many cancers studied to date, including cancer of the colon, lung, prostate, ovary, and breast.

Citations

Title Year Applications Sample Species Sample Sample Details